Loading…
Back To Schedule
Wednesday, June 21 • 8:00am - 9:30am
#302: Does Diversity Matter in Clinical Trials?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Feedback form is now closed.
Component Type: Session
Level: Intermediate
CE: ACPE 1.50 Knowledge UAN: 0286-0000-17-567-L04-P; CME 1.50; IACET 1.50; RN 1.50

As we seek to ensure that the right medicines are available for the right patients at the right time, the representation of appropriate population groups in clinical trials is increasingly important. In this DIAmond session, a multi-stakeholder panel takes a 360 degree view of the issue of diversity in today’s clinical trials. What constitutes a diverse, representative population for a clinical trial? Does the focus on personalized medicine have an impact on the context of diversity? What is the status of including more diverse populations in clinical trials, and is progress consistent for racial/ethnic minority, female, and elderly populations? What is the outlook for current efforts and initiatives to address these issues?

Learning Objectives

Describe the current status of clinical trials in the US in terms of appropriate diversity among study participants; Discuss the factors that determine appropriate diversity within clinical study populations; Identify and discuss at least two current initiatives that address the need to diversify the make-up of clinical study populations.

Chair

Joe V. Selby

Speaker

Panelist
John Whyte, MD, MPH

Panelist
Sam S. Oh, PhD, MPH

Panelist
Karen Brooks, PhD

Panelist
Nikos Dedes

Panelist
Regina Greer-Smith, MPH


Speakers
avatar for Karen Brooks

Karen Brooks

Senior Director, Clinical Operations, Adare Pharmaceuticals
ND

Nikos Dedes

Representative, European AIDS Treatment Group (EATG), European AIDS Treatment Group (EATG)
Nikos Dedes has been involved in the HIV/AIDS field since 1995 and is currently the Chair of the Policy working group of the EATG (European AIDS Treatment Group), co-chair of the EU HIV/AIDS Civil Society Forum and co-chair of the Patients’ and Consumers’ Working Party at the... Read More →
avatar for Regina Greer-Smith

Regina Greer-Smith

President, Healthcare Research Associates LLC
Regina Greer-Smith, MPH LFACHE is the President of Healthcare Research Associates LLC and creator of The S.T.A.R. Initiative. Her work involves programs and initiatives between minority, vulnerable populations, and researchers to enable participation in clinical trials. The S.T.A.R... Read More →
avatar for Sam Oh

Sam Oh

Director of Epidemiology, Asthma Collaboratory, UCSF School of Medicine
Sam is passionate about resolving difficult public health problems that affect underdog communities that are too often ignored in biomedical research. Racial and ethnic minorities currently make up 40% of the US population yet have been represented in only 4.4% of NIH-funded pulmonary... Read More →
avatar for Joe Selby

Joe Selby

Executive Director, Patient-Centered Outcomes Research Institute (PCORI)
A family physician, clinical epidemiologist, and health services researcher, Dr. Selby has more than 35 years of experience in patient care, research, and administration. He is responsible for identifying strategic issues and opportunities for PCORI and implementing and administering... Read More →
avatar for John Whyte

John Whyte

Director, Professional Affairs and Stakeholder Engagement, OCD, CDER, FDA

Wednesday June 21, 2017 8:00am - 9:30am CDT
S100c McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  12: DIAmond, Session
  • format json
  • Featured Topics Clinical Operations,Statistics,Rare Disease,Patient Centric ,Academic Clinical Researcher,Real World Evidence,StudentProgramming
  • Credit Type ACPE, CME, IACET, RN
  • Tags Session